DYADIC INTERNATIONAL INC (DYAI) Fundamental Analysis & Valuation

NASDAQ:DYAI • US26745T1016

Current stock price

0.825 USD
-0.04 (-4.07%)
Last:

This DYAI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. DYAI Profitability Analysis

1.1 Basic Checks

  • In the past year DYAI has reported negative net income.
  • DYAI had a negative operating cash flow in the past year.
  • DYAI had negative earnings in each of the past 5 years.
  • DYAI had a negative operating cash flow in each of the past 5 years.
DYAI Yearly Net Income VS EBIT VS OCF VS FCFDYAI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -5M -10M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -74.05%, DYAI is doing worse than 66.60% of the companies in the same industry.
  • DYAI's Return On Equity of -597.59% is on the low side compared to the rest of the industry. DYAI is outperformed by 80.19% of its industry peers.
Industry RankSector Rank
ROA -74.05%
ROE -597.59%
ROIC N/A
ROA(3y)-71.74%
ROA(5y)-69.53%
ROE(3y)-316.11%
ROE(5y)-221.45%
ROIC(3y)N/A
ROIC(5y)N/A
DYAI Yearly ROA, ROE, ROICDYAI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -100 -200 -300 -400 -500

1.3 Margins

  • With a decent Gross Margin value of 24.93%, DYAI is doing good in the industry, outperforming 71.26% of the companies in the same industry.
  • In the last couple of years the Gross Margin of DYAI has grown nicely.
  • The Profit Margin and Operating Margin are not available for DYAI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 24.93%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.38%
GM growth 5Y17.25%
DYAI Yearly Profit, Operating, Gross MarginsDYAI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600 -800

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. DYAI Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, DYAI has more shares outstanding
  • DYAI has more shares outstanding than it did 5 years ago.
  • DYAI has a worse debt/assets ratio than last year.
DYAI Yearly Shares OutstandingDYAI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
DYAI Yearly Total Debt VS Total AssetsDYAI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M

2.2 Solvency

  • Based on the Altman-Z score of -12.31, we must say that DYAI is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of DYAI (-12.31) is worse than 77.67% of its industry peers.
  • DYAI has a Debt/Equity ratio of 4.08. This is a high value indicating a heavy dependency on external financing.
  • DYAI's Debt to Equity ratio of 4.08 is on the low side compared to the rest of the industry. DYAI is outperformed by 81.55% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.08
Debt/FCF N/A
Altman-Z -12.31
ROIC/WACCN/A
WACCN/A
DYAI Yearly LT Debt VS Equity VS FCFDYAI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M

2.3 Liquidity

  • DYAI has a Current Ratio of 2.68. This indicates that DYAI is financially healthy and has no problem in meeting its short term obligations.
  • DYAI has a Current ratio of 2.68. This is in the lower half of the industry: DYAI underperforms 67.38% of its industry peers.
  • A Quick Ratio of 2.68 indicates that DYAI has no problem at all paying its short term obligations.
  • The Quick ratio of DYAI (2.68) is worse than 65.44% of its industry peers.
Industry RankSector Rank
Current Ratio 2.68
Quick Ratio 2.68
DYAI Yearly Current Assets VS Current LiabilitesDYAI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. DYAI Growth Analysis

3.1 Past

  • DYAI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -24.00%.
  • Looking at the last year, DYAI shows a very negative growth in Revenue. The Revenue has decreased by -11.59% in the last year.
  • The Revenue has been growing by 14.07% on average over the past years. This is quite good.
EPS 1Y (TTM)-24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16%
Revenue 1Y (TTM)-11.59%
Revenue growth 3Y1.79%
Revenue growth 5Y14.07%
Sales Q2Q%-30.78%

3.2 Future

  • The Earnings Per Share is expected to decrease by -436.57% on average over the next years. This is quite bad
  • DYAI is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 72.75% yearly.
EPS Next Y58.87%
EPS Next 2Y-436.57%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year75.06%
Revenue Next 2Y87.11%
Revenue Next 3Y102.96%
Revenue Next 5Y72.75%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
DYAI Yearly Revenue VS EstimatesDYAI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 20M 40M 60M 80M
DYAI Yearly EPS VS EstimatesDYAI Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -2 -4 -6

More info and screens

Find the best growth stocksShow best growing peers

0

4. DYAI Valuation Analysis

4.1 Price/Earnings Ratio

  • DYAI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DYAI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DYAI Price Earnings VS Forward Price EarningsDYAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DYAI Per share dataDYAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.1 -0.2

4.3 Compensation for Growth

  • A cheap valuation may be justified as DYAI's earnings are expected to decrease with -436.57% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-436.57%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. DYAI Dividend Analysis

5.1 Amount

  • DYAI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DYAI Fundamentals: All Metrics, Ratios and Statistics

DYADIC INTERNATIONAL INC

NASDAQ:DYAI (4/27/2026, 3:03:20 PM)

0.825

-0.04 (-4.07%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-25
Earnings (Next)05-07
Inst Owners16.86%
Inst Owner Change-5.27%
Ins Owners15.37%
Ins Owner Change2.64%
Market Cap30.06M
Revenue(TTM)3.09M
Net Income(TTM)-7.36M
Analysts82.86
Price Target7.14 (765.45%)
Short Float %0.48%
Short Ratio1.76
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-31.06%
Min EPS beat(2)-35.76%
Max EPS beat(2)-26.36%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-27.44%
Min Revenue beat(2)-58.72%
Max Revenue beat(2)3.83%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)20%
EPS NQ rev (3m)20%
EPS NY rev (1m)4.76%
EPS NY rev (3m)4.76%
Revenue NQ rev (1m)-16.16%
Revenue NQ rev (3m)-16.16%
Revenue NY rev (1m)-8.84%
Revenue NY rev (3m)-8.84%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 9.73
P/FCF N/A
P/OCF N/A
P/B 24.39
P/tB 24.39
EV/EBITDA N/A
EPS(TTM)-0.25
EYN/A
EPS(NY)-0.1
Fwd EYN/A
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)-0.16
OCFYN/A
SpS0.08
BVpS0.03
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -74.05%
ROE -597.59%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 24.93%
FCFM N/A
ROA(3y)-71.74%
ROA(5y)-69.53%
ROE(3y)-316.11%
ROE(5y)-221.45%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.38%
GM growth 5Y17.25%
F-Score1
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 4.08
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.68
Quick Ratio 2.68
Altman-Z -12.31
F-Score1
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16%
EPS Next Y58.87%
EPS Next 2Y-436.57%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-11.59%
Revenue growth 3Y1.79%
Revenue growth 5Y14.07%
Sales Q2Q%-30.78%
Revenue Next Year75.06%
Revenue Next 2Y87.11%
Revenue Next 3Y102.96%
Revenue Next 5Y72.75%
EBIT growth 1Y-21.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-43.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-43.46%
OCF growth 3YN/A
OCF growth 5YN/A

DYADIC INTERNATIONAL INC / DYAI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of DYADIC INTERNATIONAL INC (DYAI) stock?

ChartMill assigns a fundamental rating of 2 / 10 to DYAI.


Can you provide the valuation status for DYADIC INTERNATIONAL INC?

ChartMill assigns a valuation rating of 0 / 10 to DYADIC INTERNATIONAL INC (DYAI). This can be considered as Overvalued.


How profitable is DYADIC INTERNATIONAL INC (DYAI) stock?

DYADIC INTERNATIONAL INC (DYAI) has a profitability rating of 1 / 10.


Can you provide the financial health for DYAI stock?

The financial health rating of DYADIC INTERNATIONAL INC (DYAI) is 2 / 10.